Executive pay
Reviva Pharmaceuticals Holdings (RVPH) executive compensation
What Reviva Pharmaceuticals Holdings, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2025 proxy statement
Laxminarayan Bhat, PhD paid $607,500 (-78% on the year).
Filed Nov 04, 2025